Order Article Reprints

Mondi A, Pinnetti C, Lorenzini P, Plazzi MM, Abbate I, Camici M, Agrati C, Grilli E, Gili F, Esvan R, et al. Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection. Pharmaceuticals. 2022; 15(4):403. https://doi.org/10.3390/ph15040403

Mondi, Annalisa, Carmela Pinnetti, Patrizia Lorenzini, Maria Maddalena Plazzi, Isabella Abbate, Marta Camici, Chiara Agrati, Elisabetta Grilli, Francesca Gili, Rozenn Esvan, and et al. 2022. "Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection" Pharmaceuticals 15, no. 4: 403. https://doi.org/10.3390/ph15040403

Mondi, A., Pinnetti, C., Lorenzini, P., Plazzi, M. M., Abbate, I., Camici, M., Agrati, C., Grilli, E., Gili, F., Esvan, R., Orchi, N., Rozera, G., Amendola, A., Forbici, F., Gori, C., Gagliardini, R., Bellagamba, R., Ammassari, A., Cicalini, S., ... Antinori, A. (2022). Virological and Immunological Outcomes of an Intensified Four-Drug versus a Standard Three-Drug Antiretroviral Regimen, Both Integrase Strand Transfer Inhibitor-Based, in Primary HIV Infection. Pharmaceuticals, 15(4), 403. https://doi.org/10.3390/ph15040403